Skip to content
BioCina
  • About Us
    • Our Company
      • About BioCina
      • Our History
      • Mission and Vision
      • Executive Leadership
    • Facilities
      • Adelaide
      • Perth
  • Our Services
    • Drug Product Offerings
      • Blow Fill Seal
      • Multi Format Vials
      • Cytotoxic / High Potency
      • Vials, Pre-filled Syringes (PFS), Cartridges
    • Drug Substance Offerings
      • Microbial
      • pDNA
      • mRNA
      • LNP
    • Services
      • Technology Transfer
      • Process Development
      • Analytical Development
      • cGMP Manufacturing
      • Sterile Filling
        • Clinical Trial Supply
        • Commercial Supply
        • Orphan Drug Manufacture
      • Quality & Regulatory
      • cGMP Warehousing
  • News, Insights & Resources
    • News
      • Press Releases
      • Events
    • Thought Leadership
      • Research
      • White Papers
    • Resources
      • Videos
      • Fact Sheets
      • Case Studies
  • Careers
    • Join Our Team
      • A Career at BioCina
      • Current Job Openings
  • Policies
    • Our Policies
      • Quality Policy
      • EHS Policy
      • Privacy Policy
      • Whistleblower Policy
  • Contact Us
BioCina

Microbial CDMO Services for Biologics Manufacturing

Our team offers tremendous experience in microbial-based process development and clinical and commercial manufacturing. As a leading microbial CDMO, our SMEs hold an average tenure of 15+ years at the Adelaide site.

Our approach to process development emphasizes Quality by Design from the outset. As part of our microbial CDMO services, we work closely with our clients to fully understand the concept product and establish a Quality Target Product Profile (QTPP). From the profile, we develop a process and a control strategy to ensure our client’s product and process can be relied upon to be robust, stable, and suitably designed for future scale-up. Our manufacturing processes utilise fully enclosed, single-use systems for both buffers and process intermediates, helping ensure sanitary conditions throughout manufacturing.

Our state-of-the-art facility supports our microbial CDMO services by offering development and manufacturing equipment to seamlessly scale-up from laboratory bench to commercial production scale.

BioCina’s knowledge and experience as a microbial CDMO, partnering with clients from pre-clinical development to commercial production, ensures we are capable of navigating your journey to approval.

Microbial Manufacturing Equipment and Technology

BioCina’s state-of-the-art facility delivers industry-leading microbial CDMO capabilities, supporting high-quality GMP manufacturing, including cell banking and large-scale production. Our infrastructure is designed to enable efficient upstream and downstream processing, purification, and scalable manufacturing using both single-use and stainless steel system.

Our microbial equipment and technology includes:

  • Single-use fermentation up to 300 L and up to 500 L stainless steel fermentation, supporting flexible GMP manufacturing
  • Advanced upstream and midstream processing capability, including continuous flow centrifugation and high-pressure homogenization
  • Cell lysis technology for efficient product recovery
  • Refolding capacity up to 3,000 L for complex protein production
  • Downstream purification systems, including AKTA™ Isocratic and AKTA™ Gradient Chromatography skids and columns
  • UNIFLUX™ and Repligen Tangential Flow Filtration Systems for high-efficiency purification and concentration

End-to-End Microbial CDMO Services

Our microbial CDMO services support every stage of development, from clinical stages to full commercial manufacturing.

Quality and Regulatory Services BioCina

Quality &
Regulatory

From clinical development to commercial scale, we manufacture your microbial products with a focus on quality and scalability. Our microbial CDMO services offer full GMP compliance and global regulatory support, streamlining approvals to ensure your product is market-ready worldwide.

Read More
BioCina Process Development

Process
Development

A full-service offering that can take you from gene sequence to Master Cell Bank, including microbial strain development and upstream & downstream optimization. Our approach ensures processes are fully developed and ready for seamless scale-up to our production fermenters and purification systems within GMP-compliant suites.

Read More
Analytical Development BioCina

Analytical
Development

Development of new analytical methods, including method validation and tech transfer of established methods. Our capabilities also include comprehensive product characterization and stability testing to ensure product quality, consistency, and regulatory readiness.

Read More

cGMP
Manufacturing

Featuring a hybrid manufacturing model with both stainless steel and single-use fermenter systems for drug substance (DS) production, enabling seamless clinical to commercial scale and supporting efficient biologics manufacturing within a single highly integrated facility.

Read More

Technology
Transfer

Our systematic technology transfer approach includes thorough gap analysis and robust risk mitigation, enabling seamless scale-up and effective knowledge transfer across development and manufacturing stages.

Read More

Microbial CDMO Expertise & Insights

Explore insights, case studies, and industry updates related to microbial CDMO services and biologics manufacturing.

BioCina Initiates Comprehensive Manufacturing Program for Patrys’ Proprietary Injectable Therapeutic to Alleviate Delirium

March 17, 2026
|
Press Releases
BioCina Pty Ltd., announced it has initiated a comprehensive CMC (Chemistry, Manufacturing, and Controls) program for...

BioCina Attending Biotech Showcase During JPM Week

December 11, 2025
|
Events
We’re excited to announce that the BioCina team will be attending Biotech Showcase during JPM Week!

BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer

October 29, 2025
|
Press Releases
BioCina, a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dr. Thomas Broudy...

We Want to Hear From You

Contact Us
  • About Us
    • Our Company
      • About BioCina
      • Our History
      • Mission and Vision
      • Executive Leadership
    • Facilities
      • Adelaide
      • Perth
  • Our Services
    • Drug Product Offerings
      • Blow Fill Seal
      • Multi Format Vials
      • Cytotoxic / High Potency
      • Vials, Pre-filled Syringes (PFS), Cartridges
    • Drug Substance Offerings
      • Microbial
      • pDNA
      • mRNA
      • LNP
    • Services
      • Technology Transfer
      • Process Development
      • Analytical Development
      • cGMP Manufacturing
      • Sterile Filling
        • Clinical Trial Supply
        • Commercial Supply
        • Orphan Drug Manufacture
      • Quality & Regulatory
      • cGMP Warehousing
  • News, Insights & Resources
    • News
      • Press Releases
      • Events
    • Thought Leadership
      • Research
      • White Papers
    • Resources
      • Videos
      • Fact Sheets
      • Case Studies
  • Careers
    • Join Our Team
      • A Career at BioCina
      • Current Job Openings
  • Policies
    • Our Policies
      • Quality Policy
      • EHS Policy
      • Privacy Policy
      • Whistleblower Policy
  • Contact Us
OUR VISION

To be the most client-centric and reliable CDMO, accelerating therapies to market and enriching the lives of all stakeholders.

OUR MISSION

We provide everything clients value the most.
We keep our commitments through unrivaled quality and industry-leading on-time and in-full delivery, every step of the way.

About Us
Menu
  • Our Company
  • About BioCina
  • Our History
  • Mission and Vision
  • Executive Leadership
Menu
  • Facilities
  • Adelaide
  • Perth
Careers
Menu
  • Join Our Team
  • A Career at BioCina
  • Current Job Openings
Our Services
Menu
  • Drug Substance Offerings
  • Microbial
  • pDNA
  • mRNA
  • LNP
Menu
  • Drug Product Offerings
  • Blow Fill Seal
  • Multi Format Vials
  • Cytotoxic / High Potency
  • Vials, Pre-filled Syringes (PFS), Cartridges
Menu
  • Services
  • Technology Transfer
  • Process Development
  • Analytical Development
  • cGMP Manufacturing
  • Sterile Filling
    • Clinical Trial Supply
    • Commercial Supply
    • Orphan Drug Manufacture
  • Quality & Regulatory
  • cGMP Warehousing
News, Insights & Resources
Menu
  • News
  • Press Releases
  • Events
Menu
  • Thought Leadership
  • Research
  • White Papers
Menu
  • Resources
  • Videos
  • Fact Sheets
  • Case Studies
Policies
Menu
  • Quality Policy
  • EHS Policy
  • Privacy Policy
OUR VISION

To be the most client-centric and reliable CDMO, accelerating therapies to market and enriching the lives of all stakeholders.

About Us
Menu
  • Our Company
  • About BioCina
  • Our History
  • Mission and Vision
  • Executive Leadership
Our Services
Menu
  • Drug Substance Offerings
  • Microbial
  • pDNA
  • mRNA
  • LNP
News, Insights & Resources
Menu
  • News
  • Press Releases
  • Events
Careers
Menu
  • Join Our Team
  • A Career at BioCina
  • Current Job Openings
OUR MISSION

We provide everything clients value the most.
We keep our commitments through unrivaled quality and industry-leading on-time and in-full delivery, every step of the way.

Menu
  • Facilities
  • Adelaide
  • Perth
Menu
  • Drug Product Offerings
  • Blow Fill Seal
  • Multi Format Vials
  • Cytotoxic / High Potency
  • Vials, Pre-filled Syringes (PFS), Cartridges
Menu
  • Thought Leadership
  • Research
  • White Papers
Policies
Menu
  • Quality Policy
  • EHS Policy
  • Privacy Policy
Menu
  • Services
  • Technology Transfer
  • Process Development
  • Analytical Development
  • cGMP Manufacturing
  • Sterile Filling
    • Clinical Trial Supply
    • Commercial Supply
    • Orphan Drug Manufacture
  • Quality & Regulatory
  • cGMP Warehousing
Menu
  • Resources
  • Videos
  • Fact Sheets
  • Case Studies

© 2025 BioCina. All Rights Reserved.

X-twitter Linkedin-in